Brief: CSL Seqirus Expands U.S. Availability Of Influenza Vaccine
29/09/2026 16:32
BRIEF-CSL Seqirus Expands U.S. Availability Of Influenza Vaccine Sept 29 (Reuters) - CSL Seqirus:
CSL SEQIRUS EXPANDS U.S. AVAILABILITY OF INFLUENZA VACCINE FOLLOWING SUCCESSFUL COMPLETION OF THE 2026/27 MANUFACTURING CAMPAIGN
Source text: ID:nPn8rtPgta
Further company coverage: CSL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CSL
See all newsBrief: CSL To Defend Class Action
Australia's CSL hit with shareholder class action suit over earnings guidance (updated)
Australia's CSL faces investor proceeding over disclosure obligations
Citi says CSL's CEO pick brings key strengths
Australia's CSL names GSK executive Waterhouse as next CEO (updated)